61
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Non-viral methods for gene transfer towards osteosarcoma therapy

&
Pages 184-189 | Received 15 Nov 2006, Accepted 19 Jan 2007, Published online: 08 Oct 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

You-Kyoung Kim, Mei Zhang, Jin-Jian Lu, Fengguo Xu, Bao-An Chen, Lei Xing & Hu-Lin Jiang. (2016) PK11195-chitosan-graft-polyethylenimine-modified SPION as a mitochondria-targeting gene carrier. Journal of Drug Targeting 24:5, pages 457-467.
Read now
Matthew L Broadhead, Jonathan CM Clark, Peter FM Choong & Crispin R Dass. (2010) Making gene therapy for osteosarcoma a reality. Expert Review of Anticancer Therapy 10:4, pages 477-480.
Read now

Articles from other publishers (3)

Yunlan Fang, Xuguang Chen & W.T. Godbey. 2019. Principles of Regenerative Medicine. Principles of Regenerative Medicine 741 759 .
Obeid M. Malekshah, Xuguang Chen, Alireza Nomani, Siddik Sarkar & Arash Hatefi. (2016) Enzyme/Prodrug Systems for Cancer Gene Therapy. Current Pharmacology Reports 2:6, pages 299-308.
Crossref
Mei Zhang, You-Kyoung Kim, Pengfei Cui, Jialiang Zhang, Jianbin Qiao, Yujing He, Jinyuan Lyu, Chengqiong Luo, Lei Xing & Hulin Jiang. (2016) Folate-conjugated polyspermine for lung cancer–targeted gene therapy. Acta Pharmaceutica Sinica B 6:4, pages 336-343.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.